Máj- és epeúti rák: vizsgálatok itt: Spanyolország
56 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Badajoz, Barcelona, Madrid, Pamplona, Santander, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - 2. fázisTaking peopleAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 226 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00 - 3. fázisTaking peopleA Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid, Santander
- Életkor
- 18 év and over
- People
- 1100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07221253 · EU 2025-523085-24-00 - 2. fázisTaking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Barcelona, Córdoba, Madrid, Málaga, Sevilla
- Életkor
- 18 év to 130 év
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - 1. fázisFut, nem toborozA Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
- Where
- Madrid
- Életkor
- 18 év and over
- People
- 232 worldwide
- Run by
- AbbVie
See details and how to joinNCT06858813 · EU 2024-518012-39-00 - 1/2. fázisTaking peopleSafety of HRX215 in Patients After Minor and Major Liver Resection
- Where
- Madrid, Valencia
- Életkor
- 18 év to 75 év
- People
- 80 worldwide
- Run by
- HepaRegeniX GmbH
See details and how to joinNCT06638502 - 1/2. fázisTaking peopleSafety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- Where
- Barcelona, Madrid, Málaga, Seville
- Életkor
- 18 év and over
- People
- 225 worldwide
- Run by
- Tango Therapeutics, Inc.
See details and how to joinNCT05732831 - 2. fázisFut, nem toborozStudy of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT05727176 · EU 2023-503665-39-00 - 3. fázisTaking peopleA Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician’s Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR) altered, Chemotherapy- and FGFR Inhibitor-Refractory/Relapsed Cholangiocarcinoma (FIRST-308)
- Where
- Barcelona, Córdoba, Madrid, Pamplona, Santiago de Compostela, Zaragoza
- Életkor
- 18 év and over
- People
- 126 worldwide
- Run by
- Transthera Sciences (Nanjing) Inc.
See details and how to join2023-505660-11-00 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Barcelona, Madrid, Santiago de Compostela, Sevilla, Valencia
- Életkor
- 8 év and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - 1. fázisTaking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid
- Életkor
- 18 év and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - 2. fázisTaking peopleRandomized Study to Evaluate Melphalan/HDS Treatment Followed by Trifluridine–tipiracil plus Bevacizumab Versus Trifluridine–tipiracil plus Bevacizumab Alone in Metastatic Colorectal Cancer Patients
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid
- Életkor
- 18 év and over
- People
- 35 worldwide
- Run by
- Delcath Systems Inc.
See details and how to join2024-520356-24-00 - No phaseTaking peopleUnravelling the Impact of Radiofrecuency in Liver Surgery: the Key to Decrease Local Recurrence?
- Where
- Barcelona
- Életkor
- 18 év and over
- People
- 720
- Run by
- Hospital del Mar
See details and how to joinNCT05492136 - No phaseTaking peopleDRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
- Where
- Badalona, Barcelona
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- Maastricht University Medical Center
See details and how to joinNCT07717437 - 2. fázisTaking peopleStudy to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC
- Where
- Badalona, Barakaldo, Barcelona, Córdoba, Girona, Madrid, Málaga, Santander, Valencia
- Életkor
- 18 év and over
- People
- 90
- Run by
- Fundacion Clinic per a la Recerca Biomédica
See details and how to joinNCT07018947 · EU 2025-521459-22-00 - 1/2. fázisTaking peopleA Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- Where
- Barcelona, Córdoba, El Palmar, Madrid, Seville, Tarragona, Valencia
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Alentis Therapeutics AG
See details and how to joinNCT07169734 · EU 2025-521441-24-00 - 1. fázisTaking peopleIs CT 01 safe to use alone or combined with Everolimus for inoperable advanced liver cancer?
- Where
- Barcelona, Madrid, Valencia
- Életkor
- 18 év and over
- People
- 154 worldwide
- Run by
- Captor Therapeutics S.A.
See details and how to join2024-511435-10-00 - No phaseTaking peopleLiver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Perihilar Cholangiocarcinoma. A Prospective Multicenter Study.
- Where
- Barcelona
- Életkor
- 18 év to 70 év
- People
- 34
- Run by
- Hospital Vall d'Hebron
See details and how to joinNCT04378023 - 4. fázisTaking peopleA Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
- Where
- Barcelona, Madrid, Valencia
- Életkor
- 18 év and over
- People
- 50 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06887348 · EU 2025-521621-33-00 - No phaseCsak meghívásosAnalysis of the Incidence of Cholangiocarcinoma on Choledochal Cyst in a Western Center
- Where
- Huelva
- People
- 300
- Run by
- María Teresa Moreno Asencio
See details and how to joinNCT05404503 - 4. fázisNot yet taking people in SpanyolországHOPE Against Cancer Recurrence in HCC
- Where
- Barcelona
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Philipp Dutkowski
See details and how to joinNCT06717919 - No phaseCsak meghívásosPrehabilitation and Posttransplant Training Program in Liver Transplantation
- Where
- Valencia
- Életkor
- 18 év and over
- People
- 60
- Run by
- Maria dels Angels Cebria i Iranzo, PT, PhD
See details and how to joinNCT04246970 - No phaseCsak meghívásosInternational Registry of Congenital Portosystemic Shunt (IRCPSS)
- Where
- Barcelona
- Életkor
- 1 nap and over
- People
- 500 worldwide
- Run by
- Prof. Valérie Mc Lin
See details and how to joinNCT06041906 - 2. fázisTaking peopleA Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC
- Where
- Barcelona, Madrid, Oviedo, Pamplona
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Akeso
See details and how to joinNCT06984718 · EU 2025-524591-30-00 - 3. fázisTaking peopleThe ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma
- Where
- Alcorcón, Alicante, Badajoz, Badalona, Barcelona, Cadiz, Jaén, Madrid, Majadahonda, Málaga, Santander, Sevilla
- Életkor
- 18 év and over
- People
- 434 worldwide
- Run by
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
See details and how to joinNCT04803994 · EU 2024-512953-26-00